Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04055844
What this trial is testing

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Study completedNCT01716793
What this trial is testing

Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

Who this might be right for
Leukemia, Myelocytic, Acute
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias 354
Testing effectiveness (Phase 2)Study completedNCT06865352
What this trial is testing

Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Not applicableLooking for participantsNCT06773871
What this trial is testing

Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions

Who this might be right for
Myelodysplastic SyndromeCytopenia
Rigshospitalet, Denmark 36
Early research (Phase 1)Ended earlyNCT00234000
What this trial is testing

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center 1
Not applicableUnknownNCT01889407
What this trial is testing

Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 94
Large-scale testing (Phase 3)Study completedNCT00469144
What this trial is testing

IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeLeukemiaAcute Myeloid Leukemia
M.D. Anderson Cancer Center 233
Not applicableLooking for participantsNCT06928909
What this trial is testing

Leukemia Adapted Protocol

Who this might be right for
Acute Myeloid Leukaemia
Baylor College of Medicine 30
Large-scale testing (Phase 3)Enrolling By InvitationNCT06544109
What this trial is testing

Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

Who this might be right for
Acute Promyelocytic Leukemia
The First Affiliated Hospital of Soochow University 98
Very early researchNot Yet RecruitingNCT06786299
What this trial is testing

Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia(AML)
First Affiliated Hospital of Zhejiang University 18
Early research (Phase 1)Study completedNCT01378416
What this trial is testing

Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
Leukemia
Eisai Inc. 16
Testing effectiveness (Phase 2)Ended earlyNCT03113071
What this trial is testing

Safety and Activity of Digoxin With Decitabine in Adult AML and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Fox Chase Cancer Center 1
Early research (Phase 1)Not Yet RecruitingNCT07841002
What this trial is testing

CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML)
Liping Dou 12
Testing effectiveness (Phase 2)Study completedNCT01295307
What this trial is testing

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 86
Early research (Phase 1)WithdrawnNCT05720988
What this trial is testing

Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03701295
What this trial is testing

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLLeukemia CutisRecurrent Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT07512700
What this trial is testing

Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia

Who this might be right for
Acute Monocytic Leukemia
Chinese PLA General Hospital 204
Testing effectiveness (Phase 2)Ended earlyNCT00509600
What this trial is testing

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT02259231
What this trial is testing

RTA 408 Capsules in Patients With Melanoma - REVEAL

Who this might be right for
MelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma
Biogen 41
Not applicableStudy completedNCT06463639
What this trial is testing

FLT3 Clonal Evolution in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital 1,213
Next Page